Go Back

Bio Weekly: Aubrai Initializing, Open-Source BioAgents, Hypothesize-To-Earn

DeSci
Tech
Contents

Highlights from the last week in the biosphere:

  • The first BioAgent, Aubrai, is launching this Monday August 25 on the Bio Launchpad. Co-developed by VitaDAO and Bio, Aubrai is trained on the unpublished lab data of longevity scientist Aubrey de Grey and as well as knowledge collected from researchers worldwide via social media, messaging platforms and the Aubrai terminal. Aubrai integrates its intelligence with onchain features for knowledge management, incentivization and experiment funding to accelerate longevity research.
  • Hypothesize to Earn: As part of the upcoming Aubrai launch, BioXP is being awarded to users who yap with @Aubrai_ and generate the best longevity hypotheses, with 1M BioXP being rewarded to 5 users.
  • LP Fees Surge: Bio Protocol generated over $4m in liquidity fees the past few weeks through liquidity management of $BIO/BioDAO, demonstrating power of Bio's liquidity engine to generate revenue and grow Protocol-Owned Liquidty (POL).
  • Open-Source Agents: We open-sourced the BioAgent framework, enabling devs and researchers worldwide to build on BioAgents and soon deploy agents of their own across a range of scientific domains and operations. Check the code on Github & read the Docs.

👾 Aubrai Initializing: The First BioAgent Launch

  • Launching this Monday August 25th on Bio, Aubrai is the first decentralized scientific agent for longevity research. You can now prompt Aubrai on social by tagging @Aubrai_, with hypotheses hashed on Base through Molecule's Proof-of-Invention (POI).
  • Eventually, Aubrai's hypotheses can attract funding from the agent's LP fees and tokenize knowledge assets as IP-Tokens to accelerate the path from hypothesis to commercial application.
  • The Aubrai dashboard is live, tracking  hypotheses generated, knowledge ingested, IP-NFTs and other agent analytics. The Aubrai terminal is currently in Private Beta, with verified researchers including those with .edu emails getting expedited access. Sign up for Beta access.
  • Stay tuned for more BioAgents being deployed by BioDAOs and in partnership with top researchers in their fields, including BiomeAI and D1CKGPT.

Learn more about Aubrai and see details for the upcoming $AUBRAI Ignition Sale:

AUBRAI Ignition Sale Details:

  • The sale lasts 24 hours on the Bio Launchpad.
  • During the sale, pledge BioXP and commit BIO to qualify for an allocation.
  • Your allocation will be determined following the 24h period based on your pledged BioXP relative to the total pledged BioXP.
  • As long as you pledge BioXP in the sale period, you'll be eligible for an allocation.
  • FDV is set at ~$269K during the sale; after the sale, AUBRAI is expected to list on an AMM at ~$896K FDV.
  • Allocations are capped at 0.5% of the total supply, with any unused BioXP or BIO returned to users after the sale.
  • $AUBRAI will go live for open-market trading within hours of the sale closing.

More details in the announcement and in our docs.

Hypothesize to Earn: 1M BioXP Boost for Generating Longevity Hypotheses with Aubrai

Participate in the "Hypothesize to Earn" BioXP Contest, with 200K BioXP being awarded to the 5 best Aubrai hypotheses.

How to Participate:

  1. Tag @Aubrai_ with a prompt e.g., “@Aubrai"
  2. He’s still getting warmed up, so be patient
  3. Get him to generate an interesting hypothesis about longevity science (e.g., a new compound, process, experiment)
  4. We've extended submissions via this form to August 25 09:00 UTC for the chance to with BioXP to use in the Aubrai Ignition Sale.

🌐 Ecosystem Updates

Bio Community Updates

🧪 Explore new DeSci projects in the Bio Ecosystem on the Bio App

Stay updated via our Telegram, Discord & Governance forum. Follow @BioProtocolEco on X for real-time ecosystem updates.

https://www.bio.xyz/blog-posts/bio-weekly-aubrai-initializing-open-source-bioagents-hypothesize-to-earn